uniQure announces FDA approval of first gene therapy for adults with hemophilia B
November 22, 2022 16:40 ET | uniQure Inc.
~ Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX...